Insider Transactions in Q3 2022 at Cerevel Therapeutics Holdings, Inc. (CERE)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2022
|
Deval L Patrick |
SELL
Open market or private sale
|
Direct |
47,705
-100.0%
|
$1,431,150
$30.78 P/Share
|
|
Sep 12
2022
|
Deval L Patrick |
BUY
Exercise of conversion of derivative security
|
Direct |
47,705
+50.0%
|
$572,460
$12.62 P/Share
|
|
Sep 08
2022
|
Abraham Ceesay President |
SELL
Open market or private sale
|
Direct |
19,210
-100.0%
|
$614,720
$32.5 P/Share
|
|
Sep 08
2022
|
Abraham Ceesay President |
BUY
Exercise of conversion of derivative security
|
Direct |
19,210
+50.0%
|
$249,730
$13.17 P/Share
|
|
Aug 22
2022
|
Abraham Ceesay President |
SELL
Open market or private sale
|
Direct |
9,605
-100.0%
|
$307,360
$32.5 P/Share
|
|
Aug 22
2022
|
Abraham Ceesay President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,605
+50.0%
|
$124,865
$13.17 P/Share
|
|
Aug 16
2022
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,425,000
+17.95%
|
$49,875,000
$35.0 P/Share
|
|
Aug 15
2022
|
Abraham Ceesay President |
SELL
Open market or private sale
|
Direct |
9,606
-100.0%
|
$326,604
$34.12 P/Share
|
|
Aug 15
2022
|
Abraham Ceesay President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,606
+50.0%
|
$124,878
$13.17 P/Share
|
|
Aug 10
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
55,000
-75.05%
|
$2,200,000
$40.64 P/Share
|
|
Aug 10
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+39.18%
|
$330,000
$6.89 P/Share
|
|
Aug 08
2022
|
Scott Akamine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$400,000
$40.0 P/Share
|
|
Aug 08
2022
|
Scott Akamine Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$130,000
$13.17 P/Share
|
|
Aug 08
2022
|
Abraham Ceesay President |
SELL
Open market or private sale
|
Direct |
19,211
-75.0%
|
$730,018
$38.63 P/Share
|
|
Aug 08
2022
|
Abraham Ceesay President |
BUY
Exercise of conversion of derivative security
|
Direct |
19,211
+50.0%
|
$249,743
$13.17 P/Share
|
|
Aug 08
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-78.72%
|
$370,000
$37.75 P/Share
|
|
Aug 08
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+44.05%
|
$30,000
$3.5 P/Share
|
|
Aug 05
2022
|
Abraham Ceesay President |
SELL
Open market or private sale
|
Direct |
38,424
-100.0%
|
$1,229,568
$32.5 P/Share
|
|
Aug 05
2022
|
Abraham Ceesay President |
BUY
Exercise of conversion of derivative security
|
Direct |
38,424
+50.0%
|
$499,512
$13.17 P/Share
|
|
Aug 05
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-88.09%
|
$640,000
$32.5 P/Share
|
|
Aug 05
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+46.83%
|
$60,000
$3.5 P/Share
|
|
Jul 20
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-90.24%
|
$750,000
$30.0 P/Share
|
|
Jul 20
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+47.43%
|
$75,000
$3.5 P/Share
|
|
Jul 06
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,105
-29.01%
|
$35,360
$32.5 P/Share
|
|
Jul 06
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,105
+22.49%
|
$3,315
$3.5 P/Share
|
|
Jul 05
2022
|
John Renger Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-90.24%
|
$750,000
$30.0 P/Share
|
|
Jul 05
2022
|
John Renger Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+47.43%
|
$75,000
$3.5 P/Share
|